The recovery phase after anaesthesia is a fundamental pillar in ensuring patient safety and safe discharge from the operating theatre. Dealing with this phase requires a precise understanding of the risk factors for nausea and vomiting and systematic follow-up of the recovery of vital functions.
PONV Risk Assessment and Pharmacological Prophylaxis
The risk of PONV depends on the four Apfel risk factors: the patient being female, a non-smoker, having a history of motion sickness or PONV, and the use of postoperative opioids (postoperative opioids). The level of risk rises as these factors accumulate, from about 10% when they are absent, to 21% with one factor, and 39% with two factors, reaching 61% and 79% with three or four factors respectively. Prophylaxis includes Dexamethasone at a dose of 4 mg IV given at induction, while Ondansetron, a 5-HT3 antagonist, is given at a dose of 4 mg IV near the end of the surgical operation. Other options also include anti-emetics such as Droperidol, a butyrophenone D2 antagonist, and Metoclopramide, a D2 antagonist, in addition to Cyclizine, an H1 antagonist with anticholinergic activity (anticholinergic activity).
Complications of the Emergence Phase: Delirium and Shivering
In the recovery unit the patient may experience disturbances such as Emergence delirium, a phenomenon that usually resolves spontaneously within 5–15 minutes; however, it obliges the anaesthetist to exclude important causes including hypoxaemia (hypoxaemia), carbon dioxide retention (hypercarbia), low blood sugar (hypoglycaemia), and bladder distension (bladder distension). On the other hand, postoperative shivering (postoperative shivering) imposes a considerable burden because it increases oxygen consumption (O2 consumption) and raises carbon dioxide production (CO2 production). Shivering is treated effectively by forced-air warming (forced-air warming) together with intravenous Meperidine.
Residual Neuromuscular Block and Discharge Criteria
Residual neuromuscular block (residual neuromuscular block) is defined as a TOF ratio of less than 0.9 when measured at the adductor pollicis. This deficit poses a clinical risk because it weakens airway tone and increases the risk of aspiration (aspiration), and it should be noted that the absence of tactile fade on manual examination does not exclude the presence of this block. To ensure the safety of discharge, the Modified Aldrete score is applied, which assesses five criteria: respiration, oxygenation, circulation, consciousness, and movement (with scores from 0 to 2 for each), where a score of ≥9 is required to permit transfer of the patient.
- The risk of PONV graduates according to the Apfel criteria from 10% to 79% depending on the number of the four factors present.
- Dexamethasone is given at a dose of 4 mg intravenously at induction, while Ondansetron is injected at a dose of 4 mg intravenously near the end of surgery.
- Emergence delirium requires immediate exclusion of hypoxaemia, hypercarbia, hypoglycaemia and bladder distension.
- Postoperative shivering is treated with forced-air warming and IV meperidine to prevent increased oxygen consumption and carbon dioxide production.
- Safe discharge from recovery is achieved by obtaining a score of ≥9 on the Modified Aldrete score and excluding residual block (TOF ratio ≥0.9).
Sources
- Pharmacology and Physiology for Anesthesia, p. 517
- Pharmacology and Physiology for Anesthesia, pp. 517–518
- Smith and Aitkenhead's Textbook of Anaesthesia, 8th ed., pp. 125–127
- Miller's Anesthesia, 9th ed., p. 2607
- Miller's Anesthesia, 9th ed., p. 3902
- Miller's Anesthesia, 9th ed., p. 1390
- Morgan & Mikhail's Clinical Anesthesiology, 7th ed., p. 1256
Test yourself: 7 questions on this topic and many more →
Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.